Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.31 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.31 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.31 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL74357 | 1.00 | GRIK1 (0.31) | GRIK1GRIA2GRIA4GRIK3GRIK5 | |
| SCHEMBL27805093 | 0.98 | GRIK1 (0.31) | GRIK1GRIA2GRIA4GRIK3GRIK5 | |
| Acrylic Acid SCHEMBL22129799 | 0.90 | LMNA (0.39) | — | |
| Acrylic Acid SCHEMBL22129805 | 0.90 | LMNA (0.39) | — | |
| SCHEMBL8214063 | 0.83 | ALDH1A1 (0.31) | KDM4EMEN1POLBMAPTKMT2A | |
| SCHEMBL8214068 | 0.83 | ALDH1A1 (0.31) | KDM4EMEN1POLBMAPTKMT2A | |
| SCHEMBL2798720 | 0.83 | PTPN1 (0.33) | — | |
| SCHEMBL2798717 | 0.83 | PTPN1 (0.33) | — | |
| SCHEMBL4045909 | 0.82 | CHRM1 (0.39) | GRIK1GRIK2POLBKMT2A | |
| SCHEMBL4045908 | 0.82 | CHRM1 (0.39) | GRIK1GRIK2POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1893 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-3471831-B1 | ONE PART ACRYLIC NAIL FORMULATION | MYCONE DENTAL SUPPLY CO INC (US) | 2026-01-07 | — | — | EP | claimed |
| EP-4673187-A1 | LIQUID EMBOLIC MATERIALS | Boston Scientific Scimed Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| EP-4413055-B1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | LUBRIZOL ADVANCED MAT INC (US) | 2025-12-03 | — | — | EP | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| EP-3847220-B1 | UV-CURABLE HOT MELT ADHESIVE COMPOSITIONS FOR FLOORING APPLICATIONS | BASF SE (DE) | 2025-03-05 | — | — | EP | claimed |
| US-12187885-B2 | Waterborne coating compositions | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| WO-2024206400-A1 | LIQUID EMBOLIC MATERIALS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240325594-A1 | LIQUID EMBOLIC MATERIALS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-03 | — | — | US | claimed |
| EP-3700979-B1 | CURABLE POLYORGANOSILOXANE COMPOSITION, CURED BODY OBTAINED BY CURING SAID COMPOSITIONS, AND ELECTRONIC DEVICE COMPRISING THE SAME | DOW SILICONES CORP (US) | 2024-05-08 | — | — | EP | claimed |
| US-6020438-A | EMULSION POLYMER | THE B. F. GOODRICH COMPANY (US) | 2000-02-01 | — | — | US | claimed |
| EP-0774471-B1 | Process in suspension for preparing acrylic polymers | ATOCHEM ELF SA (FR) | 1999-06-23 | — | — | EP | claimed |
| US-5705580-A | Process for preparing beads of polymers having an acrylic basis | ATOHAAS HOLDING C.V. (NL) | 1998-01-06 | — | — | US | claimed |
| EP-0790261-A2 | Process for preparing beads of polymers having an acrylic basis | ATOHAAS HOLDING C.V. (NL) | 1997-08-20 | — | — | EP | claimed |
| EP-0774471-A1 | Process in suspension for preparing acrylic polymers | ATOHAAS HOLDING C.V. (NL) | 1997-05-21 | — | — | EP | claimed |
| EP-0458082-B1 | Encapsulated toner compositions | XEROX CORP (US) | 1996-09-04 | — | — | EP | claimed |
| US-5486563-A | STAR POLYMER | SHELL OIL COMPANY (US) | 1996-01-23 | — | — | US | claimed |
| EP-0526520-B1 | MILDNESS ADDITIVES FOR SKIN CLEANSING COMPOSITIONS | MINNESOTA MINING & MFG (US) | 1994-11-30 | — | — | EP | claimed |
| EP-0402085-B1 | Water-based protective compositions for coating films and preparation processes thereof | NIPPON OIL CO LTD (JP) | 1994-02-16 | — | — | EP | claimed |
| EP-0067067-B1 | DRY-DEVELOPING NEGATIVE RESIST COMPOSITION | FUJITSU LIMITED (JP) | 1985-09-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | GRIK1 2308/4885GRIA2 2768/4885GRIA4 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.